On the pharmacology of a benzoquinolizine derivative: Ro 4-1284.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006973:Hypertension / Q000139:chemically induced / Q000188:drug therapy; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects; D001743:Urinary Bladder / Q000187:drug effects
D006584:Hexamethonium Compounds; D010879:Piperazines; D011807:Quinolizines; D001285:Atropine; D009638:Norepinephrine; D004837:Epinephrine